Abiopharma

News list

DAVIS A BRIAN 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000966

Full text

News bot Jan. 12, 2026, 9:06 p.m.
🔍 DAVIS A BRIAN (Executive)

Company: Grace Therapeutics, Inc. (GRCE)

Report Date: 2026-01-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 10,000
Detailed Transactions and Holdings:
- Acquired 10,000 shares of Stock Option (Right to Buy) at $3.8 per share (Derivative)
  Date: 2026-01-08 | Code: A | Expires: 2036-01-08 | equity_swap_involved: 0 | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date.